Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)

被引：0
|
作者：
Sanambar Sadighi
Mohammad Ali Mohagheghi
Ali Montazeri
Zahra Sadighi
机构：
[1] Tehran University of Medical Sciences,Cancer Research Center, Cancer Institute, Imam Hospital
[2] Iranian Institute for Health Sciences Research,undefined
来源：
BMC Cancer | / 6卷
关键词：
Gastric Cancer; Docetaxel; Epirubicin; Advanced Gastric Cancer; Group Physical Functioning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Interim safety analysis of a phase III trial with 5-FU, oxaliplatin, and docetaxel (FLOT) versus epirubicin, cisplatin, and 5-FU (ECF) in patients with locally advanced, resectable gastric/oesophagogastric junction (OGJ) cancer: The AIO-sto-0210 FLOT4 study
    Pauligk, Claudia
    Meiler, Johannes
    Hofheinz, Ralf Dieter
    Kopp, Hans-Georg
    Mayer, Frank
    Schmalenberg, Harald
    Luley, Kim
    Haag, Georg Martin
    Schmiegel, Wolff H.
    Homann, Nils
    Probst, Stephan
    Koenigsmann, Michael
    Prasnikar, Nicole
    Trojan, Jorg
    Egger, Matthias
    Mahlberg, Rolf
    Heike, Michael
    Tannapfel, Andrea
    Jaeger, Elke
    Al-Batran, Salah-Eddin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] A PHASE-II TRIAL OF 5-FU, ADRIAMYCIN AND CISPLATIN (FAP) IN ADVANCED GASTRIC-CANCER
    WOOLLEY, P
    SMITH, F
    ESTEVEZ, R
    GISSELBRECHT, C
    ALVAREZ, C
    BOIRON, M
    MACHADO, C
    LAGARDE, C
    SCHEIN, P
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 455 - 455
  • [23] Final results of a randomized phase III trial of docetaxel, carboplatin and 5FU versus epirubicin, cisplatin and 5FU for locally advanced gastric cancer
    Elsaid, AA
    Elkerm, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 311S - 311S
  • [24] AN ECONOMIC EVALUATION OF CAPECITABINE/CISPLATIN PLUS 5-FU/CISPLATIN REGIMENS IN TREATMENT OF ADVANCED GASTRIC CANCER IN SPAIN
    Darba, J.
    Restovic, G.
    Ramirez de Arellano, A.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A466 - A466
  • [25] Phase II study of paclitaxel, cisplatin, and 5-FU combination chemotherapy in patients with advanced gastric cancer
    Cho, S.
    Shim, H.
    Lee, S.
    Ahn, J.
    Yang, D.
    Kim, Y.
    Park, C.
    Lee, J.
    Chung, I.
    Kim, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU for the patients with advanced hypopharyngeal cancer: Second report.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Ogawa, Takenori
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin
    Boku, Narikazu
    Ohtsu, Atsushi
    Yoshida, Shigeaki
    Shirao, Kuniaki
    Shimada, Yasuhiro
    Hyodo, Ichinosuke
    Saito, Hiroshi
    Miyata, Yoshinori
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (04) : 275 - 281
  • [28] Advanced gastric cancer associated with DIC successfully treated with 5-FU and cisplatin: A case report
    Matsumoto, S
    Kiba, T
    Numata, K
    Ihata, Y
    Morita, K
    Kitamura, T
    Saito, S
    Nakatani, Y
    Tanaka, K
    Sekihara, H
    [J]. HEPATO-GASTROENTEROLOGY, 2002, 49 (43) : 153 - 156
  • [29] Pharmacokinetics of cisplatin and combination chemotherapy of cisplatin plus 5-FU
    Saijo, N
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (03) : 157 - 157
  • [30] Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
    Pera, M.
    Gallego, R.
    Montagut, C.
    Martin-Richard, M.
    Iglesias, M.
    Conill, C.
    Reig, A.
    Balague, C.
    Petriz, L.
    Momblan, D.
    Bellmunt, J.
    Maurel, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (03) : 664 - +
12345